Physician profile
David Wilkett
NPI 1922080860
$24,514.28
in general payments reported to CMS, 2019-2025
46 companies · $4,922 in 2025
The $4,922 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,977 · 2020: $2,211 · 2021: $3,495 · 2022: $4,345 · 2023: $3,997 · 2024: $2,566 · 2025: $4,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,075 · Travel and Lodging: $2,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,075.26 |
| Travel and Lodging | $2,410.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,934.79 | 2019-2025 | Cardiomems, Gallant, Mitraclip |
| Boston Scientific Corporation | $3,756.52 | 2019-2025 | General - Therapies, Eluvia, Cds Broad Portfolio Offering |
| Elutia, INC. | $1,768.84 | 2019-2024 | Ecm Patch,Pouch |
| Novartis Pharmaceuticals Corporation | $1,738.83 | 2019-2025 | Leqvio |
| Ge Healthcare | $1,539.41 | 2024-2025 | |
| Abiomed | $1,369.89 | 2019-2024 | Impella |
| Siemens Medical Solutions USA, INC. | $1,311.62 | 2025 | Somatom Pro.Pulse |
| Janssen Pharmaceuticals, INC | $755.96 | 2019-2023 | Xarelto |
| Impulse Dynamics (USA) INC. | $600.39 | 2023-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $557.28 | 2019-2025 | Lifevest |
| Amgen INC. | $466.14 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $454.07 | 2021-2025 | Verquvo, Capvaxive |
| Cathworks, INC. | $394.44 | 2024-2025 | Ffrangio |
| Edwards Lifesciences Corporation | $363.42 | 2019-2022 | |
| Pfizer INC. | $350.35 | 2019-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $318.32 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $314.70 | 2019-2023 | Andexxa, Brilinta |
| Surmodics, INC. | $274.31 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Esperion Therapeutics, INC. | $209.07 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $209.06 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.34 | 2021-2024 | Jardiance |
| Scpharmaceuticals INC. | $182.23 | 2024-2025 | |
| Philips North America LLC | $178.20 | 2022-2024 | (Ck4) Mcot |
| Penumbra, INC. | $164.91 | 2025 | Indigo System |
| Baxter Healthcare | $159.64 | 2023-2025 | Perclot, Hillrom - Cardiac Ambulatory Monitor, Floseal |
| Kestra Medical Technology Services, INC. | $148.43 | 2025 | Assure Wcd |
| Heartflow, INC. | $140.93 | 2023-2024 | Ffrct |
| Chiesi USA, INC. | $98.79 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $90.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.05 | 2021-2025 | |
| Angiodynamics, INC. | $50.96 | 2025 | Alphavac |
| Irhythm Technologies, INC. | $49.62 | 2022-2023 | Zio Xt Patch |
| Getinge USA Sales, LLC | $37.68 | 2020 | |
| Novo Nordisk INC | $36.87 | 2023-2024 | Ozempic, Rybelsus |
| Depuy Synthes Sales INC. | $24.55 | 2025 | |
| W. L. Gore & Associates, INC. | $23.74 | 2022 | |
| Lantheus Medical Imaging, INC. | $21.28 | 2024 | |
| Amarin Pharma, INC. | $20.15 | 2019 | |
| Inari Medical, INC. | $18.02 | 2022 | |
| Cvrx, INC. | $16.58 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $16.46 | 2020 | |
| La Jolla Pharmaceutical Company | $16.40 | 2022 | |
| Medtronic, INC. | $14.53 | 2021 | |
| Amryt Pharma Holdings LTD | $14.50 | 2021 | |
| Nuwellis, INC. | $12.70 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wilkett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.